FDA Inspection 1226674 — Patrick Winiger, MD
The FDA completed an inspection of Patrick Winiger, MD on Dec 14, 2023 in Belfast. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 14, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Belfast (United Kingdom)
Additional Details
Clinical BA/BE